top of page

Search


Psilocybin Study in Nature Neuroscience Splits Brain Rewiring from Trip
UC Santa Cruz researchers found that psilocybin grows new neural connections in mice within 24 hours, through a route that can be separated from the head twitch used as a proxy for a trip.
The separation relied on genetically engineering one receptor in one cell type, so it explains the biology but does not offer a drug design.
2 days ago


Infinite Roots sells mushrooms in over 1,000 stores while its mycelium waits on Brussels
Infinite Roots has launched a button-mushroom Umami Block, taking its MushRoots range to more than 1,000 stores in Germany and Austria.
The block contains no mycelium, so it needs no EU novel food approval, unlike the fermentation technology the company was founded on.
3 days ago


KÄÄPÄ Biotech Maps Chaga Evidence to Ageing Biomarkers in New White Paper
Too long to read? KÄÄPÄ Biotech and MycoStories have published Beyond Skin Deep, a white paper that maps the evidence on Chaga (Inonotus obliquus) against the twelve Hallmarks of Ageing and finds the current evidence base touches nine of them. The framework shifts functional mushroom positioning away from surface claims such as skin appearance and energy towards measurable, hallmark-level biomarkers, anchored by an acute human trial of KÄÄPÄ's standardised NordRelease® Chaga
Nov 11


MUSHEEZ® Brings Mushroom Research to the Menu
A research-inspired recipe book, new food and beverage opportunities and an exclusive BIOVIT™ distribution agreement highlight the Estonian supplier’s latest developments. Article written in partnership with MUSHEEZ®. Too long to read? Estonian functional mushroom extract supplier MUSHEEZ® has published Functional Mushrooms on the Menu, a book of 17 food and drink ideas, each built on a published study, ahead of Fi Europe in Frankfurt on 17–19 November 2026. Each concept sets
Nov 6


Building Intellectual Property within Fungal Biotechnology: Where Fungi fit in U.S. IP Law
A patent provides a limited period of market exclusivity to the owner of a new, useful and nonobvious invention, in exchange for public disclosure of the invention. The inventor explains how to make and use the invention, and the owner gains the right to exclude others from making, using, selling, offering to sell or importing the claimed invention. Following an intensive examination at the U.S. Patent and Trademark Office (USPTO), enforceable patent claims issue and generall
Nov 5
bottom of page
